Corticotropin-releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats

被引:71
|
作者
Larauche, Muriel [1 ,2 ,3 ,8 ]
Bradesi, Sylvie [1 ,2 ,3 ,8 ]
Million, Mulugeta [1 ,2 ,3 ,8 ]
McLean, Peter [9 ]
Tache, Yvette [1 ,2 ,3 ,8 ]
Mayer, Emeran A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
McRoberts, James A. [1 ,2 ,3 ]
机构
[1] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Ctr Neruovisceral Sci & Womens Hlth, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Ctr Ulcer Res & Educ, Digest Dis Res Ctr, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA
[6] Univ Calif Los Angeles, Dept Behav Sci, Los Angeles, CA 90095 USA
[7] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA
[8] Greater Los Angeles Healthcare Syst, Vet Affairs, Los Angeles, CA USA
[9] GlaxoSmithKline, Neurol & Gastrointestinal Ctr Excellence Drug Dis, Harlow, Essex, England
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2008年 / 294卷 / 04期
关键词
visceral nociception; astressin; CP-154,526; water avoidance;
D O I
10.1152/ajpgi.00507.2007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Corticotropin-releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats. Am J Physiol Gastrointest Liver Physiol 294: G1033-G1040, 2008. First published February 28, 2008; doi:10.1152/ajpgi.00507.2007.- Visceral hypersensitivity has been implicated as an important pathophysiological mechanism in functional gastrointestinal disorders. In this study, we investigated whether the sustained visceral hyperalgesia induced by repeated psychological stress in rats involves the activation of CRF1 signaling system using two different antagonists. Male Wistar rats were exposed to 10 consecutive days of water avoidance stress ( WAS) or sham stress for 1 h/day, and the visceromotor response to phasic colorectal distension (CRD) was assessed before and after the stress period. Animals were injected subcutaneously with the brain penetrant CRF1 antagonist, CP-154,526, acutely ( 30 min before the final CRD) or chronically ( via osmotic minipump implanted subcutaneously, during stress) or with the peripherally restricted, nonselective CRF1 and CRF2 antagonist, astressin, chronically ( 15 min before each stress session). Repeated WAS induced visceral hypersensitivity to CRD at 40 and 60 mmHg. CP-154,526 injected acutely significantly reduced stress-induced visceral hyperalgesia at 40 mmHg but not at 60 mmHg. Chronic subcutaneous delivery of astressin reduced the stress-induced visceral hyperalgesia to baseline at all distension pressures. Interestingly, chronically administered CP-154,526 eliminated hyperalgesia and produced responses below baseline at 40 mmHg and 60 mmHg, indicating a hypoalgesic effect of the compound. These data support a major role for CRF1 in both the development and maintenance of visceral hyperalgesia induced by repeated stress and indicate a possible role of peripheral CRF receptors in such mechanisms.
引用
收藏
页码:G1033 / G1040
页数:8
相关论文
共 50 条
  • [41] Involvement of vasopressin 3 receptors in chronic psychological stress-induced visceral hyperalgesia in rats
    Bradesi, Sylvie
    Martinez, Vicente
    Lao, Lijun
    Larsson, Hakan
    Mayer, Emeran A.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 296 (02): : G302 - G309
  • [42] Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation
    Cheng, Haiying
    Zhou, Ligang
    Zhu, Wanling
    Wang, Ajin
    Tang, Chuyan
    Chan, Owen
    Sherwin, Robert S.
    McCrimmon, Rory J.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 293 (03): : E705 - E712
  • [43] Repeated restraint stress-induced increase in baroreceptor reflex sensitivity: Role of corticotropin-releasing factor
    Conti, LH
    Shannon, MH
    Murry, JD
    Printz, MP
    NEUROPEPTIDES, 2001, 35 (02) : 71 - 81
  • [44] Effects of corticotropin-releasing factor receptor antagonists on sexual behavior suppressed by psychological stress in male rats
    Miwa, Yoshiji
    Nagase, Keiko
    Kaneda, Taisei
    Oyama, Nobuyuki
    Akino, Hironobu
    Yokoyama, Osamu
    JOURNAL OF UROLOGY, 2008, 179 (04): : 338 - 338
  • [45] Toxicity of Pexacerfont, a Corticotropin-Releasing Factor Type 1 Receptor Antagonist, in Rats and Dogs
    White, Melvin R.
    Graziano, Michael J.
    Sanderson, Thomas P.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2019, 38 (02) : 110 - 120
  • [46] Delayed stress-induced colonic hypersensitivity in male Wistar rats: role of neurokinin-1 and corticotropin-releasing factor-1 receptors
    Schwetz, I
    Bradesi, S
    McRoberts, JA
    Sablad, M
    Miller, JC
    Zhou, HP
    Ohning, G
    Mayer, EA
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2004, 286 (04): : G683 - G691
  • [47] Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats
    Lu, L
    Liu, DH
    Ceng, XB
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 415 (2-3) : 203 - 208
  • [48] Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats
    Hotta, M
    Shibasaki, T
    Arai, K
    Demura, H
    BRAIN RESEARCH, 1999, 823 (1-2) : 221 - 225
  • [49] Central endothelin ETB receptors mediate IL-1-dependent fever induced by preformed pyrogenic factor and corticotropin-releasing factor in the rat
    Fabricio, ASC
    Rae, GA
    Zampronio, AR
    D'Orleans-Juste, P
    Souza, GEP
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2006, 290 (01) : R164 - R171
  • [50] Corticotropin-releasing factor and its receptors in the brain of rats with insulin and corticosterone deficits
    Huang, Qingling
    Timofeeva, Elena
    Richard, Denis
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2006, 37 (02) : 213 - 226